Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Daiichi Sankyo
Accenture
Cantor Fitzgerald
Argus Health
Federal Trade Commission
Healthtrust
Covington
US Army

Generated: November 18, 2018

DrugPatentWatch Database Preview

Mallinkrodt Nuclear Company Profile

« Back to Dashboard

What is the competitive landscape for MALLINKRODT NUCLEAR, and what generic and branded alternatives to MALLINKRODT NUCLEAR drugs are available?

MALLINKRODT NUCLEAR has eighteen approved drugs.



Summary for Mallinkrodt Nuclear
US Patents:0
Tradenames:15
Ingredients:15
NDAs:18

Drugs and US Patents for Mallinkrodt Nuclear

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinkrodt Nuclear ULTRATAG technetium tc-99m red blood cell kit INJECTABLE;INJECTION 019981-001 Jun 10, 1991 RX Yes Yes ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear SODIUM IODIDE I 131 sodium iodide i-131 SOLUTION;ORAL 016515-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INJECTION 018150-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear SODIUM IODIDE I 123 sodium iodide i-123 CAPSULE;ORAL 071910-001 Feb 28, 1989 AA RX No No ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear XENON XE 133 xenon xe-133 GAS;INHALATION 018327-001 Mar 9, 1982 RX No No ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 016515-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear XENON XE 133 xenon xe-133 GAS;INHALATION 018327-002 Mar 9, 1982 RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Mallinkrodt Nuclear

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mallinkrodt Nuclear TECHNESCAN MAG3 technetium tc-99m mertiatide kit INJECTABLE;INJECTION 019882-001 Jun 15, 1990 5,573,748 ➤ Sign Up
Mallinkrodt Nuclear OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 5,384,113 ➤ Sign Up
Mallinkrodt Nuclear OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 6,123,916 ➤ Sign Up
Mallinkrodt Nuclear TECHNESCAN technetium tc-99m oxidronate kit INJECTABLE;INJECTION 018321-001 Approved Prior to Jan 1, 1982 4,497,744 ➤ Sign Up
Mallinkrodt Nuclear OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 5,776,894 ➤ Sign Up
Mallinkrodt Nuclear ULTRATAG technetium tc-99m red blood cell kit INJECTABLE;INJECTION 019981-001 Jun 10, 1991 4,755,375 ➤ Sign Up
Mallinkrodt Nuclear OCTREOSCAN indium in-111 pentetreotide kit INJECTABLE;INJECTION 020314-001 Jun 2, 1994 5,753,627 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
Julphar
UBS
Express Scripts
Chinese Patent Office
QuintilesIMS
Accenture
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.